# APIDRA SOLOSTAR
> **BLA021629** · Biologics License Application · Sponsor: SANOFI AVENTIS US · Approved 2004-04-16
## Drug
- **FDA Application Number:** BLA021629
- **Application type:** Biologics License Application
- **Brand name:** APIDRA SOLOSTAR
- **Generic name:** INSULIN GLULISINE
- **Active ingredients:** INSULIN GLULISINE RECOMBINANT
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SANOFI AVENTIS US
- **Manufacturer:** sanofi-aventis U.S. LLC
- **First approval:** 2004-04-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021629)
---
*MORVS · CC0 1.0*